Crossmark

Development of an aptamer capable of multidrug resistance reversal for tumor combination chemotherapy

Crossref DOI link: https://doi.org/10.1073/pnas.2321116121

Published Online: 2024-04

Published Print: 2024-04-09

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Wen, Xiaohong

Huang, Zhixiang

Yang, Xiaohai

He, Xiaoxiao

Li, Lie

Chen, Haiyan

Wang, Kemin

Guo, Qiuping

Liu, Jianbo https://orcid.org/0000-0001-8282-4078
Funding

Funding for this research was provided by:

Foundation for Innovative Research Groups of the National Natural Science Foundation of China (21877030)

Foundation for Innovative Research Groups of the National Natural Science Foundation of China (21735002)

Foundation for Innovative Research Groups of the National Natural Science Foundation of China (22177032)

Foundation for Innovative Research Groups of the National Natural Science Foundation of China (22377025)

Foundation for Innovative Research Groups of the National Natural Science Foundation of China (21521063)
License Information

Version of Record valid from 2024-04-01
More Information

Publication History

Received: 2023-12-13

Accepted: 2024-02-26

Published: 2024-04-01